3-methylcholanthrene has been researched along with thalidomide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roe, FJ; Walters, MA | 1 |
| Miura, M; Southam, CM; Wuest, H | 1 |
2 other study(ies) available for 3-methylcholanthrene and thalidomide
| Article | Year |
|---|---|
Sensitivity of newborn mice to carcinogenic agents.
Topics: Adenocarcinoma; Adenoma; Animals; Animals, Newborn; Benz(a)Anthracenes; Carcinogens; Carcinoma, Hepatocellular; Cricetinae; Hemangioma; Hemangiosarcoma; Hydroxylamines; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma; Methylcholanthrene; Mice; Neoplasms, Experimental; Papilloma; Skin Neoplasms; Stomach Neoplasms; Thalidomide | 1968 |
Potentiating effect of thalidomide on methylcholanthrene oncogenesis in mice.
Topics: Animals; Antibody Formation; Cell Count; Cell Transformation, Neoplastic; Drug Synergism; Female; Hemolysin Proteins; Methylcellulose; Methylcholanthrene; Mice; Neoplasms, Experimental; Organ Size; Papilloma; Skin Neoplasms; Spleen; Thalidomide | 1970 |